Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Bladder Cancer

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 28 articles:
HTML format



Single Articles


    July 2008
  1. KUNZE D , Wuttig D, Fuessel S, Kraemer K, et al
    Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cells.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


    May 2008
  2. FONTANA L , Bosviel R, Delort L, Guy L, et al
    DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


  3. VASALA K , Paakko P, Turpeenniemi-Hujanen T
    Matrix metalloproteinase-9 (MMP-9) immunoreactive protein in urinary bladder cancer: a marker of favorable prognosis.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


    March 2008
  4. BERTACCINI A , Marchiori D, Cricca A, Garofalo M, et al
    Neuroendocrine carcinoma of the urinary bladder: case report and review of the literature.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


  5. STRASSER H , Amann K, Schrott KM, Krause FS, et al
    Solitary metastasis of a Merkel cell tumor to the urinary bladder.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


    January 2008
  6. PALMEIRA CA , Oliveira PA, Seixas F, Pires MA, et al
    DNA image cytometry in bladder cancer: state of the art.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


  7. BLANDAMURA S , D'Alessandro E, Giacomelli L, Guzzardo V, et al
    Expression of maspin in papillary Ta/T1 bladder neoplasms.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


    November 2007
  8. FECHNER G , Muller G, Schmidt D, Garbe S, et al
    Evaluation of hypoxia-mediated growth factors in a novel bladder cancer animal model.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


    September 2007
  9. HERRMANN E , Eltze E, Bierer S, Kopke T, et al
    VEGF-C, VEGF-D and Flt-4 in transitional bladder cancer: relationships to clinicopathological parameters and long-term survival.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  10. GABRIEL U , Bolenz C, Michel MS
    Experimental models for therapeutic studies of transitional cell carcinoma.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  11. YAO R , Lopez-Beltran A, Maclennan GT, Montironi R, et al
    Expression of S100 protein family members in the pathogenesis of bladder tumors.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


    March 2007
  12. CAMPODONICO F , Mattioli F, Manfredi V, Capponi G, et al
    Pharmacokinetics and toxicity of an early single intravesical instillation of gemcitabine after endoscopic resection of superficial bladder cancer.
    Anticancer Res. 2007;27:1179-83.
    PubMed     Related articles    Abstract available


  13. WU TF , Wu H, Wang YW, Chang TY, et al
    Prohibitin in the pathogenesis of transitional cell bladder cancer.
    Anticancer Res. 2007;27:895-900.
    PubMed     Related articles    Abstract available


  14. HAUSER PJ , Han Z, Sindhwani P, Hurst RE, et al
    Sensitivity of bladder cancer cells to curcumin and its derivatives depends on the extracellular matrix.
    Anticancer Res. 2007;27:737-40.
    PubMed     Related articles    Abstract available


  15. SCHULTZ IJ , De Kok JB, Witjes JA, Babjuk M, et al
    Simultaneous proteomic and genomic analysis of primary Ta urothelial cell carcinomas for the prediction of tumor recurrence.
    Anticancer Res. 2007;27:1051-8.
    PubMed     Related articles    Abstract available


  16. SCHULTZ IJ , Kiemeney LA, Roelofs R, Van Aarssen Y, et al
    The prognostic role of the STK15 T91A polymorphism and of STK15 mRNA expression in patients with urothelial cell carcinoma.
    Anticancer Res. 2007;27:1025-30.
    PubMed     Related articles    Abstract available


    January 2007
  17. WARE JH , Zhou Z, Guan J, Kennedy AR, et al
    Establishment of human cancer cell clones with different characteristics: a model for screening chemopreventive agents.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


    November 2006
  18. INOUE R , Matsuyama H, Yano S, Yamamoto Y, et al
    Gefitinib-related gene signature in bladder cancer cells identified by a cDNA microarray.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  19. KARAHALIL B , Kocabas NA, Ozcelik T
    DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  20. MITSOGIANNIS IC , Psaroudaki Z, Perrea D, Paniara O, et al
    In vitro biocompatibility between mitomycin-C (MMC) and bacillus Calmette-Guerin (BCG).
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


    September 2006
  21. ONAT OE , Tez M, Ozcelik T, Toruner GA, et al
    MDM2 T309G polymorphism is associated with bladder cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  22. MYLONA E , Magkou C, Gorantonakis G, Giannopoulou I, et al
    Evaluation of the vascular endothelial growth factor (VEGF)-C role in urothelial carcinomas of the bladder.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  23. WADA T , Tanji N, Ozawa A, Wang J, et al
    Mitochondrial DNA mutations and 8-hydroxy-2'-deoxyguanosine Content in Japanese patients with urinary bladder and renal cancers.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  24. KASTRITIS E , Dimopoulos MA, Antoniou N, Deliveliotis C, et al
    The outcome of patients with advanced pure squamous or mixed squamous and transitional urothelial carcinomas following platinum-based chemotherapy.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


    July 2006
  25. URECH K , Buessing A, Thalmann G, Schaefermeyer H, et al
    Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  26. OLIVEIRA PA , Palmeira C, Colaco A, de la Cruz LF, et al
    DNA content analysis, expression of Ki-67 and p53 in rat urothelial lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and treated with mitomycin C and bacillus Calmette-Guerin.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


    May 2006
  27. PERABO FG , Frossler C, Landwehrs G, Schmidt DH, et al
    Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  28. PALUBIN KM , Goodwin BL, Niesen MI, Le EA, et al
    A direct mechanistic link between growth control and a tumor cell immune function: increased interleukin-8 secretion accounts for elimination of Oct-1 antisense transformants from scid mice.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: